Stay updated on Nivolumab Combinations in EGFR+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.

Latest updates to the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2; these are maintenance changes in the page footer and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe page now shows Revision: v3.3.2 and removed Revision: v3.2.0.SummaryDifference0.0%

- Check52 days agoChange DetectedThe government funding/operating-status notice was removed from the page. No trial data or version history entries appear to be changed.SummaryDifference0.3%

- Check66 days agoChange DetectedThe new screenshot shows a minor UI refresh of the Record History page with layout and styling tweaks, while the underlying version data and study information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange Detected- Added an important operating-status notice and links (affecting user expectations and perceived reliability). - Updated version from v3.1.0 to v3.2.0.SummaryDifference8%

- Check102 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Combinations in EGFR+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.